Literature DB >> 27287041

Extracting a low-dimensional description of multiple gene expression datasets reveals a potential driver for tumor-associated stroma in ovarian cancer.

Safiye Celik1, Benjamin A Logsdon2, Stephanie Battle3, Charles W Drescher4, Mara Rendi5, R David Hawkins3,6, Su-In Lee7,8.   

Abstract

Patterns in expression data conserved across multiple independent disease studies are likely to represent important molecular events underlying the disease. We present the INSPIRE method to infer modules of co-expressed genes and the dependencies among the modules from multiple expression datasets that may contain different sets of genes. We show that INSPIRE infers more accurate models than existing methods to extract low-dimensional representation of expression data. We demonstrate that applying INSPIRE to nine ovarian cancer datasets leads to a new marker and potential driver of tumor-associated stroma, HOPX, followed by experimental validation. The implementation of INSPIRE is available at http://inspire.cs.washington.edu .

Entities:  

Keywords:  Conditional dependence; Gene expression; HOPX; Latent variable; Low-dimensional representation; Module; Tumor-associated stroma; Variable discrepancy

Mesh:

Substances:

Year:  2016        PMID: 27287041      PMCID: PMC4902951          DOI: 10.1186/s13073-016-0319-7

Source DB:  PubMed          Journal:  Genome Med        ISSN: 1756-994X            Impact factor:   11.117


  78 in total

Review 1.  EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer.

Authors:  A Singh; J Settleman
Journal:  Oncogene       Date:  2010-06-07       Impact factor: 9.867

2.  ChEA: transcription factor regulation inferred from integrating genome-wide ChIP-X experiments.

Authors:  Alexander Lachmann; Huilei Xu; Jayanth Krishnan; Seth I Berger; Amin R Mazloom; Avi Ma'ayan
Journal:  Bioinformatics       Date:  2010-08-13       Impact factor: 6.937

3.  SPARC regulates extracellular matrix organization through its modulation of integrin-linked kinase activity.

Authors:  Thomas H Barker; Gretchen Baneyx; Marina Cardó-Vila; Gail A Workman; Matt Weaver; Priya M Menon; Shoukat Dedhar; Sandra A Rempel; Wadih Arap; Renata Pasqualini; Viola Vogel; E Helene Sage
Journal:  J Biol Chem       Date:  2005-08-22       Impact factor: 5.157

4.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

5.  Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas.

Authors:  Neali D Hendrix; Rong Wu; Rork Kuick; Donald R Schwartz; Eric R Fearon; Kathleen R Cho
Journal:  Cancer Res       Date:  2006-02-01       Impact factor: 12.701

6.  The prognostic landscape of genes and infiltrating immune cells across human cancers.

Authors:  Andrew J Gentles; Aaron M Newman; Chih Long Liu; Scott V Bratman; Weiguo Feng; Dongkyoon Kim; Viswam S Nair; Yue Xu; Amanda Khuong; Chuong D Hoang; Maximilian Diehn; Robert B West; Sylvia K Plevritis; Ash A Alizadeh
Journal:  Nat Med       Date:  2015-07-20       Impact factor: 53.440

7.  A pluripotency signature predicts histologic transformation and influences survival in follicular lymphoma patients.

Authors:  Andrew J Gentles; Ash A Alizadeh; Su-In Lee; June H Myklebust; Catherine M Shachaf; Babak Shahbaba; Ronald Levy; Daphne Koller; Sylvia K Plevritis
Journal:  Blood       Date:  2009-07-27       Impact factor: 22.113

Review 8.  Oncogenic roles of EMT-inducing transcription factors.

Authors:  Alain Puisieux; Thomas Brabletz; Julie Caramel
Journal:  Nat Cell Biol       Date:  2014-06       Impact factor: 28.824

9.  Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors.

Authors:  Jason I Herschkowitz; Karl Simin; Victor J Weigman; Igor Mikaelian; Jerry Usary; Zhiyuan Hu; Karen E Rasmussen; Laundette P Jones; Shahin Assefnia; Subhashini Chandrasekharan; Michael G Backlund; Yuzhi Yin; Andrey I Khramtsov; Roy Bastein; John Quackenbush; Robert I Glazer; Powel H Brown; Jeffrey E Green; Levy Kopelovich; Priscilla A Furth; Juan P Palazzo; Olufunmilayo I Olopade; Philip S Bernard; Gary A Churchill; Terry Van Dyke; Charles M Perou
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

10.  Learning a prior on regulatory potential from eQTL data.

Authors:  Su-In Lee; Aimée M Dudley; David Drubin; Pamela A Silver; Nevan J Krogan; Dana Pe'er; Daphne Koller
Journal:  PLoS Genet       Date:  2009-01-30       Impact factor: 5.917

View more
  7 in total

1.  Comprehensive Cross-Population Analysis of High-Grade Serous Ovarian Cancer Supports No More Than Three Subtypes.

Authors:  Gregory P Way; James Rudd; Chen Wang; Habib Hamidi; Brooke L Fridley; Gottfried E Konecny; Ellen L Goode; Casey S Greene; Jennifer A Doherty
Journal:  G3 (Bethesda)       Date:  2016-12-07       Impact factor: 3.154

2.  A machine learning approach to integrate big data for precision medicine in acute myeloid leukemia.

Authors:  Su-In Lee; Safiye Celik; Benjamin A Logsdon; Scott M Lundberg; Timothy J Martins; Vivian G Oehler; Elihu H Estey; Chris P Miller; Sylvia Chien; Jin Dai; Akanksha Saxena; C Anthony Blau; Pamela S Becker
Journal:  Nat Commun       Date:  2018-01-03       Impact factor: 14.919

3.  Identifying prognostic signature in ovarian cancer using DirGenerank.

Authors:  Jian-Yong Wang; Ling-Ling Chen; Xiong-Hui Zhou
Journal:  Oncotarget       Date:  2017-07-11

4.  Differential gene expression and gene-set enrichment analysis in Caco-2 monolayers during a 30-day timeline with Dexamethasone exposure.

Authors:  J M Robinson; S Turkington; S A Abey; N Kenea; W A Henderson
Journal:  Tissue Barriers       Date:  2019-08-22

5.  Assessing reproducibility of matrix factorization methods in independent transcriptomes.

Authors:  Laura Cantini; Ulykbek Kairov; Aurélien de Reyniès; Emmanuel Barillot; François Radvanyi; Andrei Zinovyev
Journal:  Bioinformatics       Date:  2019-11-01       Impact factor: 6.937

Review 6.  Navigating Multi-Scale Cancer Systems Biology Towards Model-Driven Clinical Oncology and Its Applications in Personalized Therapeutics.

Authors:  Mahnoor Naseer Gondal; Safee Ullah Chaudhary
Journal:  Front Oncol       Date:  2021-11-24       Impact factor: 6.244

7.  The PDGF Family Is Associated with Activated Tumor Stroma and Poor Prognosis in Ovarian Cancer.

Authors:  Jiajia Li; Xiuling Zhi; Yating Sun; Mo Chen; Liangqing Yao
Journal:  Dis Markers       Date:  2022-09-26       Impact factor: 3.464

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.